HIV: The Controversy of Its Evolution

  • Thread starter Thread starter Pengwuino
  • Start date Start date
Click For Summary
SUMMARY

The discussion centers on the clinical tests of AK602, a drug showing effectiveness against HIV in 40 AIDS patients, with minimal side effects reported. The drug functions by blocking the CCR5 chemokine receptor, crucial for HIV's ability to infect immune cells. While promising, further extensive clinical trials are necessary to confirm its safety and efficacy. The conversation also raises concerns about the potential impact on the immune response, questioning whether patients may remain vulnerable to other infections.

PREREQUISITES
  • Understanding of HIV and its infection mechanisms
  • Knowledge of chemokine receptors, particularly CCR5
  • Familiarity with clinical trial processes and drug approval stages
  • Basic concepts of immune system function and response
NEXT STEPS
  • Research the mechanisms of CCR5 antagonists in HIV treatment
  • Explore the latest clinical trial results for AK602 and similar drugs
  • Investigate the implications of immune response modulation in HIV therapies
  • Learn about alternative receptors that HIV may utilize for infection
USEFUL FOR

Researchers, healthcare professionals, and anyone interested in advancements in HIV treatment and the implications of new drug therapies on immune system function.

Biology news on Phys.org
Well, from this bit:
The researchers conducted clinical tests on 40 AIDS patients in the United States.

AK602 not only proved effective against viruses that had become resistant to other drugs, but it also caused almost no side effects, the team said.(IHT/Asahi: July 7,2005)

I'd say almost no side effects in 40 patients means it might be too soon to say how safe it really is. It'll have to go to a more extensive clinical trial to be approved, and that's when we'll find out if it really is as good as the claims.
 
CCR5 is a chemokine receptor that is expressed primarily on cells of the immune system (B-cells, T-cells, macrophages). Basically, it is important for the immune response because it helps activate the cells when there is an infection. So what I think this is about is that they found something that blocks the receptor so that HIV doesn't recognize the cell since certain strains of HIV need to recognize this receptor to infect the cell. I'm not sure how novel this idea is since I think other drugs have been made with similar functions but I don't know the specifics. Also, apparently there are other receptors that HIV can recognize although I believe this is the dominant one.

Think of it like you are trying to recognize a friend in a crowd. Normally it is easy but say we make it so all the faces are blank. Then you wouldn't be able to find your friend unless there was some other factor like a tattoo (this would be alternative receptors). Blocking the receptor is like putting HIV in a crowd of cells with no faces. It doesn't know who is who.
 
detta said:
CCR5 is a chemokine receptor that is expressed primarily on cells of the immune system (B-cells, T-cells, macrophages). Basically, it is important for the immune response because it helps activate the cells when there is an infection. So what I think this is about is that they found something that blocks the receptor so that HIV doesn't recognize the cell since certain strains of HIV need to recognize this receptor to infect the cell. I'm not sure how novel this idea is since I think other drugs have been made with similar functions but I don't know the specifics. Also, apparently there are other receptors that HIV can recognize although I believe this is the dominant one.

Thanks detta. So, does this mean the person taking this drug is still going to be vulnerable to other infections, since the drug is interferring with the normal immune response? So, it might stop the HIV from infecting cells, but then leaves them still vulnerable to all the other infections people with suppressed immune systems are vulnerable to? Or does this have a different effect?
 

Similar threads

  • · Replies 14 ·
Replies
14
Views
3K
  • · Replies 2 ·
Replies
2
Views
1K
  • · Replies 15 ·
Replies
15
Views
6K
  • · Replies 63 ·
3
Replies
63
Views
11K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 4 ·
Replies
4
Views
11K
  • · Replies 11 ·
Replies
11
Views
3K
Replies
32
Views
15K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 4 ·
Replies
4
Views
3K